Clinical and Translational Biomarkers

Discovery stages of clinical support and translational biomarkers are used to identify a compound’s impact on organs or tissues before the clinical effect have been Proved. It can be classified into three general classes: target biomarkers, mechanism biomarkers and disease biomarkers. Translational biomarker is based on whether it can be detectable, measurable and, in the end, it can be able to be qualified or validated.

 

Personalized medicine in clinical and Translational biomarkers has been driven by the need to accurately predict patient response to therapy while ensuring drug efficacy and safety.

 

  • Novel Biomarkers discovery
  • Clinical and analytical biomarker validation
  • Role of Biomarkers in clinical decision making
  • Application of Biomarkers in Drug discovery and development
  • Circulating Tumor DNA cells as Biomarkers: Case studies for various cancers
  • Non-invasive Biomarker for dug toxicity studies
  • Next-Generation Sequencing (NGS) assays for Translational and Clinical Research in Oncology
  • Biomarkers in Clinical trials: Design, strategies & application case studies

Related Conference of Clinical and Translational Biomarkers

Clinical and Translational Biomarkers Conference Speakers